Andreas Poschenrieder

Title: Andreas Poschenrieder: Innovator in Modified Cyclopentapeptides

Introduction

Andreas Poschenrieder is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals through his innovative work on modified cyclopentapeptides. His research focuses on compounds that have potential applications in various medical fields.

Latest Patents

Andreas Poschenrieder holds a patent for "Modified cyclopentapeptides and uses thereof." This invention relates to a compound characterized by a specific structure, which includes iodo-substituted or methyl-substituted amino acids. The patent outlines the potential uses of these compounds in conjunction with organic complexation agents and detectable labels, particularly in the development of cytotoxic agents and other active substances.

Career Highlights

Andreas Poschenrieder is affiliated with the Technische Universität München, where he conducts his research and development activities. His work has led to advancements in the understanding and application of cyclopentapeptides in medical science. He has been recognized for his innovative approach to drug development and his contributions to the scientific community.

Collaborations

Throughout his career, Andreas has collaborated with esteemed colleagues such as Hans-Jürgen Wester and Margret Schottelius. These collaborations have further enhanced the impact of his research and have contributed to the advancement of knowledge in the field.

Conclusion

Andreas Poschenrieder is a prominent figure in the realm of pharmaceutical innovation, particularly in the area of modified cyclopentapeptides. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in medicine.